PN17 / GN3 Stocks: How to Read Troubled-Company News and When to Cut Loss

You open the morning paper: "Company X classified as PN17." Other investors panic-sell, and the share price tumbles. You glance at your portfolio - the stock may be on your holdings list. The first question that runs through your mind: should I sell immediately, or hold and hope the company recovers?

The answer is not the same for every case. Some PN17 companies eventually fully recover and their share prices bounce back hard. Others end up delisted, leaving shareholders with a total loss. Choosing between these outcomes requires understanding how the PN17 / GN3 system works, and a sober decision framework - not an emotional reaction.

This article explains what PN17 and GN3 are, the criteria that trigger the status, the timeline companies face after the announcement, the four possible outcome scenarios, and most importantly - when retail investors should cut loss versus when there is still reason to hold.

What Are PN17 and GN3?

PN17 (Practice Note 17) and GN3 (Guidance Note 3) are two status categories issued by Bursa Malaysia to listed companies facing serious financial distress.

The difference is simple:

• PN17 is for companies listed on the Main Market of Bursa Malaysia.
• GN3 is for companies listed on the ACE Market.

Both serve the same function - warning the market that the company is in critical financial condition and faces the risk of delisting if it fails to recover. The status is not just a label; it is a formal mechanism that forces the company to present a recovery plan within a set timeframe.

Bursa Malaysia publishes a monthly status report on PN17 and GN3 companies listing every company in this category and the status of their recovery plans. At the latest count, about 24 companies are under PN17/GN3 - roughly 2.3% of the 1,025 listed companies.

What Triggers PN17 Status

Understanding the criteria matters because it gives you early warning before a company enters PN17. Key triggers:

Shareholder equity collapse. Accumulated shareholders' equity falls to 25% of paid-up capital or below, AND shareholders' equity is less than RM40 million. This is the most common trigger - companies that record losses for several consecutive quarters until their capital is eroded.

Receiver or manager appointed. A receiver or manager is appointed over assets representing 50% or more of the company's total assets.

Major subsidiaries winding up. Subsidiaries or associates are wound up such that 50% or more of the company's total asset value is affected.

Qualified auditor's opinion. The auditor issues a qualified opinion or expresses going concern doubt in the financial statements.

Default on credit facility payment. The company fails to pay a material credit facility, triggering an event of default.

Business suspension. The company's main business operations are suspended for a significant period.

If you read your company's annual report and see one of these red flags - especially a qualified auditor's opinion or rapidly shrinking equity - that is a yellow light you should heed long before PN17 is announced. Learning to read an annual report properly is the best defence.

What Happens After the PN17 Announcement?

After Bursa Malaysia classifies a company as PN17, the company enters a strict timeline:

Within the first 3 months - The company must announce its intention to present a regularisation plan. This First Announcement becomes the reference for the subsequent timeline.

Within 12 months of the First Announcement - The company must submit a formal regularisation plan. There are two types of plans, as explained in a law firm's analysis on the duties of directors for PN17 companies:

• Plan A - involves a significant business change (e.g., merger, acquisition, change of core activity). Must be submitted to the Securities Commission (SC) for approval.
• Plan B - no significant business change. Must be submitted to Bursa for approval, with implementation completed within 6 months of Bursa's approval.

After the plan is approved - The company must implement the plan on the prescribed schedule.

If non-compliant - The company's shares will be suspended from trading, and eventually delisted from Bursa. Bursa usually grants several extensions, but not without limit. In 2025, for example, Reach Energy became the first company delisted that year after its third extension request was rejected.

Understanding this timeline matters for investors. A company that has just entered PN17 is materially different from one that has been in PN17 for 18 months and still has not produced a strong plan.

4 Possible Outcome Scenarios

After entering PN17, the company will ultimately arrive at one of four states. As an investor, you need to assess the probability of each scenario before making a decision.

Scenario 1: Recovery and Exit from PN17

This is the best outcome. The company successfully raises capital (rights issue, private placement), restores profitability, or restructures its debt to the point where the PN17 criteria are no longer met. After an observation period, Bursa removes the PN17 status.

Recent example: Pharmaniaga exited PN17 status in March 2026 after recording eight consecutive profitable quarters, ending a three-year PN17 spell. Capital A (the parent of AirAsia) also obtained approval for its recovery plan in March 2025.

The share prices of recovering companies often surge significantly when they exit PN17. This is because retail investors who were previously fearful start coming back, and institutional funds (which usually cannot hold PN17 stocks due to mandate restrictions) begin buying again.

Scenario 2: Still Struggling but Not Yet Recovered

The company manages to submit a plan and get it approved, but implementation takes longer than expected. They remain in PN17 but are not suspended. The Star has called this phenomenon "the slow climb out of PN17" - companies that survive but have not won.

Stocks in this scenario usually trade in a weak range with low liquidity. They can be held, but investors need patience and acceptance of volatility.

Scenario 3: Trading Suspension

When the company fails to meet the recovery plan timeline, Bursa suspends share trading. Shareholders cannot sell during the suspension. This is a dangerous phase - the company is alive on paper, but you cannot exit.

Scenario 4: Delisting

The worst outcome. The company is officially removed from Bursa. Shares become untradable on the main exchange and their value can drop to near zero, even though the company technically still exists (as an unlisted entity).

Reach Energy (April 2025) is a recent example. Retail shareholders who held until delisting often cannot recover their capital.

When Should You Cut Loss: A Decision Framework

Retail investors are often torn between two extreme pieces of advice: "sell immediately upon PN17" vs "hold and wait for recovery". Both are wrong because they ignore context. Here is a more sober framework.

Question 1: Is the recovery plan credible?

Read the company's regularisation plan announcement carefully. Does it involve a large capital injection (dilutive but real), debt restructuring with major creditors, or acquisition of a profitable new business? Or does it look vague with many "expectations" and no real commitments?

A strong plan - with a recognised sponsor, confirmed funding sources, and a realistic timeline - offers a much higher chance of recovery.

Question 2: What was the root cause of the trouble?

PN17 caused by an extraordinary one-off loss (such as Pharmaniaga's Covid vaccine inventory) is different from PN17 caused by years of ongoing operational losses. The first may recover when conditions normalise; the second requires a difficult transformation.

Crowe Malaysia compared PN17 situations to "a health check, medical operation, ICU, or mortuary" - not all PN17 companies are the same. Some only need a check-up; some are already in ICU.

Question 3: How long has it been in PN17?

A company that has just entered still has a full 12 months to submit a plan. A company that has been in PN17 for 18-24 months with repeated extensions is a red flag. Bursa can stop granting extensions at any time.

Question 4: What percentage of your portfolio is it?

If the PN17 stock is only 1-2% of your portfolio, you can hold it as a rebound speculation with controlled risk. If it is 20% of your portfolio, holding is a single very dangerous bet - cutting loss becomes a risk-management decision even if there is a chance of recovery.

Understanding proper stop loss and position sizing matters here. PN17 is one of those situations where position-sizing discipline protects you from disaster.

Question 5: Can you accept a total loss?

This is the most honest question. If the company is eventually delisted, your capital in that stock can be wiped out. If a total loss would damage your financial plan, the answer is already clear - cutting loss is the rational decision, even at a low price.

Early Warning Signs Before PN17

Disciplined investors are not caught off guard when a company enters PN17. They see the early signs:

• Recurring quarterly losses - three or four consecutive quarters of losses is a major warning.
• Rapidly shrinking shareholders' equity - compare equity in each annual report year over year. If the trend is down, PN17 risk is building.
• Qualified auditor opinion - phrases like "going concern doubt" or "material uncertainty" are the clearest warnings.
• News of late payments to suppliers or banks - media sources usually pick this up before formal PN17.
• Distressed asset sales - the company sells major business units with no clear replacement.
• Senior executives departing - especially the CFO or CEO leaving without a strong replacement.

PN17 stocks also often become targets of pump-and-dump schemes because of low prices and the liquidity spikes that come with "white knight" rumours. We have explained this pattern in depth in our article on 6 signs of fried stocks promoted by fake news - essential reading if you see a PN17 stock suddenly turn "hot".

The PN17 Recovery Trade: High Risk, but Legitimate

Some investors deliberately buy PN17 stocks in the hope of recovery. This strategy is not unreasonable - companies like Pharmaniaga and Capital A have recovered, and early shareholders made significant gains.

But the strategy requires high discipline:

• Diversify - do not put all your eggs in one PN17. Spread across several cases.
• Small position size - 1-2% of portfolio per case, not 10-20%.
• Pick PN17 stocks with strong plans - not all PN17 companies are equal; choose those with recognised sponsors and a clear root cause (not chronic operational losses).
• Patience for years - PN17 recoveries often take a full 2-3 years, not 6 months.
• Be ready to accept total loss - many of your cases may ultimately delist. The strategy only works if a few recoveries compensate for the other losses.

This is not a strategy for everyone. It requires the psychological capacity to hold stocks that keep falling, and a portfolio large enough to permit several "small bets" of high risk.

FAQ

1. Are PN17 stocks always going to be delisted? No. A large portion of companies successfully exit PN17 through implemented recovery plans. But not all - some are eventually suspended and delisted. The probability depends on the quality of the plan and the root cause.

2. What is the difference between PN17 and PN16? PN16 is a separate classification for companies with other issues - usually related to "cash company" status (a cash-only company with no main business after asset disposal). PN17 is specific to operational financial distress.

3. I already own a stock that just entered PN17. Should I sell now or wait? It depends on four factors: the quality of the recovery plan, the root cause, what percentage of your portfolio it is, and your risk tolerance. There is no single answer - use the decision framework laid out in this article.

4. Can I receive dividends from a PN17 stock? Not impossibly, but very rarely. Companies in financial distress usually suspend dividend payments while they work on restoring equity. Don't buy a PN17 stock for dividend income.

5. How long do companies usually stay in PN17? Typically 12 to 24 months for those that eventually recover. Several cases exceed 3 years with repeated extensions. The longer the stay, the higher the probability of delisting.

6. Are PN17 stocks suitable for an EPF account or retirement fund? In practice, retirement funds and the EPF usually do not hold PN17 stocks for mandate and risk reasons. As a retail investor, carefully consider whether such high-risk stocks fit your long-term objectives.

7. Is PN17 shown on my trading platform? Yes, usually. Major trading platforms such as Mplus show a warning marker (exclamation symbol or PN17 label) next to the stock name. Always check this label before buying.

8. Where does Bursa publish the PN17 list? Bursa Malaysia publishes the monthly status report on PN17 and GN3 companies on its official website. The list is constantly updated and publicly available.

Conclusion

PN17 and GN3 status is not an automatic death sentence - it is a formal warning with a clear timeline and several possible outcomes. Investors who read the announcement carefully, critically assess the recovery plan, and use a sober decision framework make better choices than those who simply react to panic.

The decision to cut loss is not a sign of defeat; it is a sign of discipline. Equally, holding a PN17 stock with a strong plan and controlled position size is not foolishness; it is a legitimate risk calculation. What matters is that you choose with eyes open, not with emotion.

Understanding PN17 mechanics is one skill; managing your portfolio through such events is the bigger one.

To act on your trade decisions with confidence - whether cutting loss or holding a recovery candidate - you need a trading account that allows fast execution. Open a CDS and trading account to invest in stocks on Bursa Malaysia as well as foreign markets such as the United States and Hong Kong.

If you are just starting out and want to understand the basics of stock investing properly, download the free Stock Market Basics Ebook as your first step.

Further Reading

• Stop Loss & Position Sizing: Cara Lindungi Modal Sebelum Beli Saham
• Cara Baca Annual Report Bursa Malaysia Tanpa Pening Kepala
• Pump and Dump Bursa Malaysia: 6 Tanda Saham 'Goreng' Yang Dipromosi Melalui Berita Palsu
• Cash Flow Statement: Cara Mengesan Prestasi Sebenar Syarikat di Bursa Malaysia
• Foreign Fund Flow: Cara Baca Data Aliran Dana Asing Untuk Predict Arah Bursa